Market News & Trends
Baxter Biologics Facility In Asia, Announces Expansion Plans
Baxter International Inc. recently announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant protein…
Biotech Forward Pharma Files for $200-Million IPO
Forward Pharma A/S, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, recently announced it has filed…
Coherus’ Biosimilar Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
Coherus BioSciences, Inc. recently announced that CHS-1420, its proposed biosimilar of adalimumab (Humira), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study…
Seventh Sense Biosystems Closes $16-Million Financing
Seventh Sense Biosystems, Inc. (7SBio), the pioneering developer of virtually painless blood collection and diagnostic platforms, recently announced a $16-million Series B financing from a…
Allergan Acquires LiRIS Program From TARIS Biomedical
Allergan Inc. and TARIS Holdings LLC recently announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program, LiRIS, which…
3M DDS Announces Collaboration With Presspart Group
ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with Presspart Group (a division of…
Ashland Commits to Major Capacity Expansion to Meet Customer Demand
Ashland Specialty Ingredients, a commercial unit of Ashland Inc. recently announced plans to significantly expand production capacity of its Klucel hydroxypropylcellulose (HPC) product line in…
Charleston Laboratories & Daiichi Sankyo Announce Major Collaboration
Charleston Laboratories, Inc., through its wholly owned subsidiary LOCL Pharma, Inc., and Daiichi Sankyo recently announced the parties have entered into a strategic collaboration for…
Sanofi & MannKind Announce Global Licensing Agreement
Sanofi and MannKind Corporation recently announced they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder,…
Immune Response BioPharma to Develop In-House Sales Force for Blockbuster Vaccine
New Jersey-based Immune Response BioPharma, Inc. recently announced its plans to create an in-house sales force for Remune, its HIV vaccine. Remune is a therapeutic…
Pharmacogenetic Testing Company Launches Robust Drug Testing Program
Pinnacle Laboratory Services has successfully launched one of the most comprehensive Pharmacogenetic programs available on the market. Pinnacle Laboratory Services specializes in Pharmacogenetic testing with…
Optibrium Launches New Software for Compound Data Visualization
Optibrium recently announced the launch of Sentira, a new desktop application that provides dynamic data visualization and analysis of compound data. Applicable across all fields…
Mexico’s Healthcare Market Value to Reach Almost $28 Billion by 2020, says GlobalData
LONDON, UK (GlobalData), 7 August 2014 - Mexico’s pharmaceutical and medical devices industries will be worth approximately $22.5 billion and $5.4 billion by 2020, respectively,…
ZIOPHARM Oncology & Solasia Pharma Announce Global License & Collaboration Agreement
ZIOPHARM Oncology & Solasia Pharma Announce Global License & Collaboration Agreement ZIOPHARM Oncology, Inc. and Solasia Pharma K.K. recently announced an amendment and restatement of…
Allied Minds & Bristol-Myers Squibb Form New Enterprise
Allied Minds & Bristol-Myers Squibb Form New Enterprise Allied Minds and Bristol-Myers Squibb Company recently announced the formation of Allied-Bristol Life Sciences LLC, a new…
Lubrizol Acquires Leading Manufacturer in Global Device Industry
The Lubrizol Corporation recently announced it has acquired Vesta, a leading contract manufacturer for the global medical device industry. This acquisition broadens Lubrizol's life science…
ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more than triple in value, from…
Ready-to-Use EZ-Fit Filtration Unit From EMD Millipore Leverages Industry Leading Technology
EMD Millipore has launched the EZ-Fit Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing. The system is more efficient than traditional methods, resulting…
Harlan Provides Expertise for Biologics & Biosimilars
Harlan Laboratories, Ltd. is prepared to meet the global demand for development programs in novel biologics and biosimilars. While the US FDA is slower to…
